Thompson Siegel & Walmsley’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-58
Closed -$5K 789
2017
Q4
$5K Hold
58
﹤0.01% 778
2017
Q3
$5K Hold
58
﹤0.01% 769
2017
Q2
$4K Hold
58
﹤0.01% 770
2017
Q1
$4K Buy
58
+33
+132% +$2.17K ﹤0.01% 761
2016
Q4
$1K Buy
+25
New +$1.32K ﹤0.01% 803

Other funds holding ADNT

Thompson Siegel & Walmsley's ADNT Position: Q1 2018 in Review

Thompson Siegel & Walmsley sold out of Adient (ADNT) in Q1 2018, closing a stake of 58 shares — an estimated $5K sold.

Thompson Siegel & Walmsley first reported a position in ADNT in Q4 2016 and held it in 5 quarters. The position peaked at $5K in Q4 2017. 402 funds tracked by Wall St. Rank hold ADNT as of Q1 2018.

  • Thompson Siegel & Walmsley reported no remaining Adient position as of Q1 2018 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 58 Adient shares in Q1 2018, an estimated $5K.
  • Thompson Siegel & Walmsley first reported a position in Adient in Q4 2016 and held it in 5 quarters.
  • Thompson Siegel & Walmsley's Adient position peaked at $5K in Q4 2017.
  • 402 funds tracked by Wall St. Rank held Adient as of Q1 2018.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2018, filed 8 May 2018.